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Abstract
Background: Biofilm production has been established as a virulence factor which allows Staphylococcus to adhere
and persist in medical devices. The objective was to determine whether therapeutic failure in patients infected
with Staphylococcus spp. is linked to biofilm production, the presence of the ica operon, and the bacterial insertion
sequence element IS256.
Methods: Staphylococcus spp. isolates from patients with device-related infections were collected. Therapeutic
failure with proper antimicrobial treatment was registered. Biofilm phenotype was determined by Congo red test
agar and Christensen assay. Presence of the ica operon genes A-D and IS256 was detected by PCR. Differences
were compared through x
2.
Results: 100 isolates from staphylococcal infections episodes were included: 40 sepsis/bacteremia, 32 ependymitis,
and 28 peritonitis. 73.77% of CoNS and 79.5% of S. aureus isolates harbored the icaD gene, 29% of all isolates
IS256-A+ IS256-D genes, icaA and icaB genes were only found in CoNS (27.8% and 21.3% respectively). Therapeutic
failure occurred in 95.4.% of patients with a positive IS256-A+ IS256-D S. epidermidis isolate, RR 5.49 (CI 95% 2.24-
13.44 p ≤ 0.0001), and 85.76% in CoNS isolates, RR 2.57 (CI 95% 0.97-6.80, p = 0.05). Although none S. aureus was
positive for IS256-A + IS256-D, therapeutic failure was observed in 35.8%.
Conclusions: The presence of icaA/D genes along with the sequence element IS256 was associated with
therapeutic failure in most CoNS infections, even though its absence in S. aureus isolates does not ensure
therapeutic success.
Background
Staphylococci inhabit the skin and mucous membranes of
animals and humans. Due to the ability to produce bio-
film, they are also a common cause of device-associated
infections [1-4]. Biofilm formation capacity is associated
with antimicrobial resistance, and considered widely as a
virulence factor. Invasive isolates are more prone to pro-
duce biofilm than carriage isolates of healthy individuals
[5,6]. Staphylococcus epidermidis was the first species to
be described as a biofilm producer; however, the same
ability is encountered in S. aureus and other coagulase-
negative Staphylococcus species [7,8].
The principal component of biofilm is a polysacchar-
ide intercellular adhesin {PIA} [9,10]. PIA is composed
of a beta-1,6-N-acetylglucosamine polymer synthesized
by an enzyme codified by the ica operon found on the
bacterial chromosome, that includes a regulating ele-
ment of four genes (A, B, C,a n dD), and a transposable
element, IS256 [11]. It is known that the A gene codifies
the N-acetylglucosamyl transferase enzyme responsible
for synthesizing PIA. This enzyme is not very active
in vitro, but co-expression of the D gene increases the
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acetylation of mature PIA and the transmembrane pro-
tein IcaC seems to be involved in externalization and
elongation of the growing polysaccharide [9,12].
The expression of the icaADBC genes is controlled by
a complex variety of conditions and factors; one of them
is the excision or insertion of the bacterial sequence ele-
ment IS256 at various locations on the operon. The
molecular basis for the regulation process is still unclear;
however, the insertion element is definitely responsible
for up to 33% of the activated portion of the operon
that allows its expression [1,10,13,14]. Other regulator
genes (RsbU, s
B, Tca-R, agr, sarA) for PIA production
have also been reported [15].
Biofilm production usually occurs in two steps, 1) the
initial step of adhesion to the surface, facilitated by
adhesive polysaccharides and/or a polysaccharide with
multiple proteins (including autolysins), and 2) the accu-
mulation of cells due to PIA production, synthesized
after activation of the ica operon [9]. Initial findings
assumed that the presence of icaADBC genes will con-
tribute to the persistence of infection and therapeutic
f a i l u r ei np r e s e n c eo fam e d i c a ld e v i c e .S o m ea u t h o r s
have tried to establish the presence of the AD genes as
a prognosis biomarker in device associated infections
[8,16]. Many other environmental conditions and the
phenotype of the Staphylococcus isolate also participate
in the regulation of biofilm production [17]. By under-
standing the different mechanisms of biofilm production
it will be possible to support the development of thera-
peutic strategies [5].
The objective of this study was to describe the asso-
ciation between biofilm production, the presence of
icaADBC genes, the bacterial insertion sequence IS256
and therapeutic failure, in isolates from patients with
medical device-related infections.
Methods
Clinical staphylococci isolates were collected prospec-
tively from hospitalized patients with a staphylococcal
medical device-related infection from September 2002
to July 2003. Isolates were obtained from blood, cere-
brospinal fluid and peritoneal fluid. The protocol was
approved by the Institutional Review Board. Patient’s
data were obtained from clinical records. Infection was
defined in accordance with internationally proposed cri-
teria [18].
Empirical antimicrobial treatment was prescribed for
all patients, and was modified according to susceptibility
patterns.
Therapeutic failure was considered:
1) For central venous catheter (CVC) related bacter-
emia/sepsis, persistence of positive blood cultures
collected through the CVC after 72 hours of admin-
istering proper antimicrobial treatment.
2) For peritonitis, persistence of positive peritoneal
fluid culture collected through peritoneal dialysis
catheter or a cellularity ≥ 100 cells per mm
3 after
72 hours of administering proper antimicrobial
treatment.
3) For ependymitis, after removal of the infected
shunt, persistence of positive cerebrospinal fluid
(CSF) culture collected through external ventricu-
lostomy, after 72 hours of systemic and/or intraven-
tricular antimicrobial treatment.
Microbiology
Staphylococcus species were identified by API-Staph sys-
tem (bioMérieux). Antimicrobial susceptibility was
determined in accordance with CLSI recommendations,
oxacillin resistant isolates were tested for mecA gene by
PCR [19,20].
The isolates were characterized phenotipically by cul-
ture on Congo red agar plates (CRA) as described by
Freeman et al. [21], with modifications as described by
Arciola et al [22]: agar plates were prepared with 0.8 g of
CRA (Sigma) and 36 g of saccharose (Sigma) to 1 liter of
brain heart infusion agar (Dibico, Mexico) and incubated
24 h at 37°C and subsequently overnight at room tem-
perature. For S. aureus CRA were kept up to 72 h.
The quantitative assay by Christensen was used to
test the ability to produce biofilm [23]. Briefly, 1:100
dilutions of overnight cultures in trypticase soy broth
were used to inoculate wells in a microtiter polystyrene
plate (Falcon, Becton Dickinson, Labware, NJ, USA).
After incubation for 24 h at 37°C, the plates were
gently washed two times with phosphate-buffered sal-
ine (PBS, 10 mM potassium phosphate, 0.15 M NaCl
pH 7.0), and stained with 1% (w/v) crystal violet solu-
tion; the excess stain was washed off with deminera-
lised water. The adherent cells were resuspended in
acid-isopropanol (5% v/v 1 M HCl in isopropanol), and
the absorbance (A) was measured at 492 nm in a
microplate reader. A biofilm producer strain was
defined as an optical density at 492 nm of ≥ 0.17. Clo-
nal relatedness of strains was excluded using Pulsed
Field Gel Electrophoresis (PFGE) [24].
The presence of the A, B, C,a n dD genes of the ica
operon and the position of the bacterial sequence ele-
ment IS256 were detected by PCR according to the pro-
tocol described by de Silva G. [6] with some
modifications: DNA extraction was performed with the
Promega® Wizard Genomic Kit (Madison, WI, USA).
Primer sequences were taken from the GenBank
sequence database of the National Center for Biotech-
nology Information [GenBank accession number
U43366 for S. epidermidis, EF546621 for S. lugdunensis].
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Page 2 of 6The sequence for the bacterial insertion element was
taken from the publication by Ziebuhr [25].
The PCR cycling conditions used were 30 cycles of
1 min of denaturation at 94°C and 2.5 min of elongation
at 72°C for all reactions, with annealing for 1 min at 60°C
(icaA), 59°C (icaB), 45°C (icaC), 59°C (icaD), or 59°C
(IS256). After amplification in a T-personal thermocycler
(Whatman Biometra GmbH, Göttingen, Germany), 5 μlo f
the PCR mixture was used in analysis for horizontal elec-
trophoresis in agarose gel of up to 2% tris-borate-EDTA.
A 100 bp ladder DNA molecular weight marker was used.
Samples with positive amplification for the A and D frag-
ments were analyzed for the presence of the insertion ele-
ment IS256, amplifying the sequence by PCR (Table 1).
S. aureus ATCC 29247 and S. epidermidis ATCC 35984
(RP62A) were used as negative and positive controls.
Only one strain of each infection episode was included
for analysis.
Statistical analysis
To compare differences between groups Mantel-Haenszel
x
2 or Fisher exact test were employed, a value of p < 0.05
was considered to be significant. Statistical analysis was
performed with SPSS for Windows software version 11.0.
Results
During the study period, one hundred isolates from
patients with diagnosis of device-related infections were
included. The episodes were divided in 40 CVC-related
bacteremias, 32 ependymitis, and 28 peritonitis. S. epi-
dermidis was isolated in 45 episodes, S. aureus in
39 and diverse coagulase negative Staphylococcus
(CoNS)non-epidermidis in 16 (S. hominis, S. haemolyti-
cus, S. lugdunensis, S. auricularis, S. warnerii and S.
sciurii). 33% of the isolates were oxacillin-resistant, 31%
were resistant to amikacin, 26% to norfloxacin and 0%
to vancomycin. According to the PFGE results, all the
strains included corresponded to a different genotype.
Biofilm production was confirmed in 22 strains by the
Christensen assay, of these, 19 had a positive phenotype
on the CRA plates. IcaADBC genes and the bacterial
insertion sequence IS256 were detected in most of the
strains, except for two strains of S. auricularis,o n eS.
warnerii and one S. sciurii. 73.77% of CoNS and 79.5%
of S. aureus isolates harbored the icaD gene; icaA, icaB
and icaC genes were present in 27.8%, 21.3% and 9.8%
of CoNS isolates (Table 2, figure 1). Only 4/39 S. aureus
isolates were positive for icaA+IcaD genes but none for
the bacterial insertion sequence. IS256-A+ IS256-D
Table 1 Primer sequences for PCR used in this study.
Primer Sequence (5’-3’) Product size (bp) PCR conditions
icaA forward
icaA reverse
GAC CTC GAA GTC AAT AGA GGT
CCC AGT ATA ACG TTG GAT ACC
814 30 s 95°C
60 s 60°C
90 s 72°C
icaB forward
icaB reverse
ATG GCT TAA AGC ACA CGA CGC
TAT CGG CAT CTG GTG TGA CAG
526 60 s 95°C
60 s 59°C
90 s 72°C
icaC forward
icaC reverse
ATA AAC TTG AAT TAG TGT ATT
ATA TAT AAA ACT CTC TTA ACA
989 30 s 95°C
60 s 42°C
90 s 72°C
IS256 forward
IS256 reverse
TGA AAA GCG AAG AGA TTC AAA GC
ATG TAG GTC CAT AAG AAC GGC
1102 60 s 94°C
60 s 59°C
90 s 68°C
icaD forward
icaD reverse
AGG CAA TAT CCA ACG GTA A
GTC ACG ACC TTT CTT ATA TT
371 60 s 94°C
60 s 59°C
150 s 72°C
Table 2 IcaADBC genes and bacterial insertion element IS256 in Staphylococcus spp. isolates from device-related
infections.
Microorganism No.
isolates
IcaA IcaB IcaC IcaD IcaA + IcaD IS256-A/IS256-D
S. epidermidis 45 23 11 4 39 22 21
S. aureus 39 4 0 0 31 4 0
S. hominis 64 0 0 6 4 3
S. haemolyticus 41 1 1 2 2 2
S. lugdunensis 21 1 1 1 1 1
S. auricularis 20 0 0 0 0 0
S. warnerii 10 0 0 0 0 0
S. sciurii 10 0 0 0 0 0
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non-epidermidis CoNS. (figure 2, figure 3).
Therapeutic failure in episodes caused by an IS256-A+
IS256-D positive strain was 95.4% for S. epidermidis,R R
5.49 (CI 95% 2.24-13.44, p ≤ 0.0001), and 85.76% in CoNS
isolates, RR 2.57 (CI 95% 0.97-6.80, p = 0.05). Although
none S. aureus was positive for IS256-A + IS256-D, thera-
peutic failure was observed in 35.8%. (Table 3).
Discussion
Biofilm production has been clearly linked to infections
in the presence of foreign bodies for various decades
[26], it has been demonstrated in vivo tests with labora-
tory animals and in vitro, that biofilm hampered thor-
ough penetration of the antimicrobial and the
concentrations require to eradicate biofilm-producing
strains are higher than those required to eradicate
strains that did not produce biofilm [27,28].
In this study, as reported by other authors, it was
found that the genes of the Ica operon frequently
appeared in strains of Staphylococcus epidermidis
[4,6,29]. The number of S. aureus isolates with a positive
biofilm phenotype or producing biofilm was low (4/39),
and in none of them the bacterial insertion element
IS256 was present. Experimental studies have also
shown that biofilm formation is possible in icaADBC
operon S. aureus mutants [30], but we did not find S.
aureus negative for the operon that was a biofilm pro-
ducer. S. epidermidis strains with the genetic determi-
nant for biofilm formation were clearly associated to a
high risk of therapeutic failure, which was not corrobo-
rated with non-epidermidis CoNS and S. aureus,p e r -
haps due to a smaller number of collected isolates.
As previously stated, adhesion to the plastic device
could be a factor linked to weaker expression of symp-
toms of infection, due to the existence of a smaller
number of circulating bacteria, most of them remaining
1500bp
500bp
IS256
icaA
1    2   3   4   5   6   7   8   9  10 11 
Figure 1 Electrophoresis of PCR products with primers for
IS256 and icaA. Lane 1, 100 bp molecular weight marker; lane 2,
negative control; lane 3, 814-bp band from icaA positive control;
lane 4 and lane 5, negative samples; lane 6, 814-bp band from S.
aureus strain; lane 7, 1102-bp band (IS256) and 814-bp band (icaA)
from S. epidermidis strain; lane 8, 1102-bp band from IS256 positive
control; lane 9, lane 10 and lane 11, 1102-bp bands (IS256) and 814-
bp bands (icaA) from S. epidermidis strains.
1500bp 
1  2  3  4 5 6 
IcaC
Figure 2 Electrophoresis of PCR products with primers for icaC.
Lane 1, 100 bp molecular weight marker; lane 2, 989-bp band from
icaC positive control; lane 3, negative control; lane 4, negative
sample; lane 5 and lane 6, 989-bp bands (icaC) from S. epidermidis
strains.
1500bp
100bp
IS256
IcaD
1  2  3  4  5  6  7 8
Figure 3 Electrophoresis of PCR products with primers for
IS256 and icaD. Lane 1, 100 bp molecular weight marker; lane 2,
371-bp band from icaD positive control; lane 3 and lane 4, 371-bp
bands (icaD) from S. haemolyticus strains; lane 5, 1102-bp band
(IS256) and 371-band (icaD) from S. haemolyticus strain; lane 6, 371-
bp band (icaD) from S. haemolyticus strain; lane 7, 1102-bp band
(IS256) and 371-band (icaD) from S. haemolyticus strain; lane 8, 371-
band (icaD) from S. haemolyticus strain.
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Page 4 of 6inside the catheter. This mild presentation could sup-
port the non-standard recommendation to preserve the
medical device in patients with bacteremia. This is
necessary in some cases due to the critical condition of
the patient. However, the risk of failure to proper anti-
microbial treatment is so high, that this conduct should
be avoided and the CVC removed as soon as possible,
even if a negative icaA +IcaD isolate is detected.
The present work has several limitations. Infections
included are difficult to compare to elicit general recom-
mendations, in particular for the ependymitis and peri-
tonitis episodes. The ica operon genes have been widely
described in Staphylococcus epidermidis and Staphylo-
coccus aureus, several authors have found similarity in
other CoNs species [6,7] but results cannot be extended
to all pathogenic species. Recently biofilm formation has
been described in detail in S. haemolyticus isolates [31].
Phenotypic variation as well as clonal lineage must be
included in future studies to develop alternative thera-
peutic strategies.
Conclusions
T h ep r e s e n c eo ficaA/D genes along with the sequence
element IS256 was associated with therapeutic failure in
most CoNS infections, even though its absence in S.
aureus isolates does not ensure therapeutic success.
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